i-Base home
Search Menu
  • Home
  • HTB
  • 2002
  • May

May 2002

Contents

Antiretrovirals

  • Hydroxyurea: in vitro evidence of potency against HIV viral reservoirs
  • Transient increases in viral load are common among people on HAART, finds a study of UK patients
  • Meta-analysis supports triple therapy for HIV infection

Pregnancy

  • Reduction of mother to child HIV-1 transmission: breastfeeding negates benefits of short course regimens
  • Nevirapine at the centre of MTCT controversy
  • Mothers, orphans, and prevention of paediatric AIDS

Side effects

  • Altered adipocyte differentiation associated with protease inhibitors and lipoatrophy
  • High mortality rate in patients with severe NRTI-associated lactic acidosis
  • Tenofovir adversely affects development in foetal monkeys
  • Tenofovir not toxic to mitochondria in human cell culture

Coinfections and complications

  • HIV infection is a risk factor for external genital warts, study suggests
  • American study finds KS-associated herpesvirus is highly prevalent among gay men

Other news

  • Gilead made misleading and illegal statements about Viread, says FDA
  • Barcelona conference organisers issue nine-point plan of action on global emergency

On the web

  • Incorporating antiretroviral resistance testing into clinical practice
  • Management of co-infection with HIV and TB

PDFs

  • Volume 3 Number 4 May 2002 PDF
  • HTB RSS

Early access

  • Vaccination is effective in limiting mpox progression – but lower efficacy in people living with HIV 27 May 2025
  • US update guidelines for statin use in people living with HIV 26 May 2025
  • HIV activists in the US call for action in JID and Zachie Achmat brings South African perspective in the Lancet 26 May 2025
  • Scientific, legal and ethical crisis from halting ongoing NIH studies: TAG statement 22 May 2025
  • All early access reports

Current issues

  • May 2025
  • April 2025
  • March 2025
  • Back issues

Special report

  • Scientific, legal and ethical crisis from halting ongoing NIH studies: TAG statement 22 May 2025

More from HTB

  • Conference reports
  • Conference shortcuts
  • Articles by subject
  • PDFs
  • Subscribe
  • HTB homepage

Home

  • i-Base homepage
  • Donate

This website sets no cookies from us or anyone else.

Information on this website is provided by treatment advocates and offered as a guide only. Decisions about your treatment should always be taken in consultation with your doctor.

HIV i-BASE
About us - Contact - Cookies and privacy - Copyright waiver - Terms of use - Home
Registered charity number: 1081905. Company number: 3962064.

Search i-Base

Site navigation

Quick links
HIV positive
Donate
Feedback
Advice and information
Q and A
Guides
HIV meds
Glossary
Research reports
HTB
HTB South
Pipeline report
Publications and resources
Publications
Other resources
Translations
Slide sets
Order and subscribe
Advocates' network
UK-CAB
Training manual
i-Base
About us
Contact
News and updates
Sitemap
Home
Find us on Facebook
i-Base on Facebook